Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125984982 | 12598498 | 2 | F | 201607 | 20160724 | 20160727 | 20160802 | EXP | CN-SA-2016SA132390 | AVENTIS | 21.00 | YR | A | F | Y | 0.00000 | 20160802 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125984982 | 12598498 | 1 | PS | THYMOGLOBULINE | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | ROUTE : IV GTT | U | UNK | 103869 | 250 | MG | |||||||
| 125984982 | 12598498 | 2 | SS | THYMOGLOBULINE | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | ROUTE : IV GTT | U | UNK | 103869 | 250 | MG | |||||||
| 125984982 | 12598498 | 3 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | ROUTE : IV PUMP | U | UNK | 0 | |||||||||
| 125984982 | 12598498 | 4 | SS | CICLOSPORIN | CYCLOSPORINE | 1 | ROUTE : IV PUMP | U | UNK | 0 | |||||||||
| 125984982 | 12598498 | 5 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125984982 | 12598498 | 6 | C | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | 0 | 1000 | MG | QD | ||||||||
| 125984982 | 12598498 | 7 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 125984982 | 12598498 | 8 | C | IMMUNOGLOBULIN HUMAN NORMAL | HUMAN IMMUNOGLOBULIN G | 1 | INTRAVENOUS INJECTION | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125984982 | 12598498 | 1 | Immunosuppression |
| 125984982 | 12598498 | 2 | Graft versus host disease |
| 125984982 | 12598498 | 3 | Immunosuppression |
| 125984982 | 12598498 | 4 | Graft versus host disease |
| 125984982 | 12598498 | 5 | Allergy prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125984982 | 12598498 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125984982 | 12598498 | Cystitis haemorrhagic | |
| 125984982 | 12598498 | Epilepsy | |
| 125984982 | 12598498 | Platelet count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125984982 | 12598498 | 1 | 20160705 | 20160706 | 0 | |
| 125984982 | 12598498 | 2 | 20160705 | 20160706 | 0 | |
| 125984982 | 12598498 | 5 | 201607 | 201607 | 0 | |
| 125984982 | 12598498 | 6 | 201607 | 0 |